InsiderClue
← All stocks

OCULAR THERAPEUTIX, INC

OCUL Net buying
CIK 0001393434 #1892 in the set updated 17 Sep 2026
Bought (120 mo)
$26.37M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$5.82M
$4.68M on a plan · $0.00 straight out of an exercise
Sold at will
$1.14M
24 of 71 sales
Net
+$20.55M
+$25.24M against sales at will

By person

28 insiders · 140 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
SUMMER ROAD LLC entity
10% owner
$23.35M (34)
—
+$23.35M
14,210,262
6.47%
$145.51M
+50.8%
Dugel Pravin
See Remarks
—
$3.00M (11) scheduled
−$3.00M
3,270,332
1.49%
$33.49M
—
Sawhney Amarpreet
Chairman of the Board
$950.29K (6)
—
+$950.29K
1,245,424
0.5671%
$12.75M
+51.6%
LINDSTROM RICHARD L MD
Director
$775.34K (3)
$143.00K (1)
+$632.34K
260,933
0.1188%
$2.67M
+499.0%
Notman Donald
Chief Operating Officer
$108.65K (3)
$455.10K (10)
−$346.45K
366,529
0.1669%
$3.75M
+1,930%
Waheed Nadia
Chief Medical Officer
—
$332.46K (4) scheduled
−$332.46K
300,079
0.1366%
$3.07M
—
Kaiser Peter
Chief Development Officer
—
$327.25K (9) scheduled
−$327.25K
264,378
0.1204%
$2.71M
+122.9%
Saroj Namrata
Chief Business Officer
—
$277.79K (1) scheduled
−$277.79K
254,620
0.1159%
$2.61M
+26.4%
Nayak Sanjay
Chief Strategy Officer
—
$261.55K (11) scheduled
−$261.55K
326,898
0.1488%
$3.35M
+226.9%
Mattessich Antony C.
President and CEO
$500.99K (6)
$269.63K (3)
+$231.36K
595,201
0.2710%
$6.09M
—
Heier Jeffrey S.
Chief Scientific Officer
$145.35K (2)
$349.48K (9) scheduled
−$204.13K
318,326
0.1449%
$3.26M
+177.5%
Bollag Daniel M
Sr. VP Reg. Affairs & Quality
$197.30K (2)
—
+$197.30K
42,100
0.0192%
$431.10K
—
Opaleye Management Inc. entity
Previously a 10% owner
$137.92K (3)
—
+$137.92K
5,122,500
2.33%
$52.45M
+0.7%
Anderman Todd
Chief Legal Officer
—
$137.37K (1) scheduled
−$137.37K
152,468
0.0694%
$1.56M
—
Hanley Kevin F.
Sr. VP Technical Operations
$111.00K (2)
—
+$111.00K
20,000
0.0091%
$204.80K
—
Ozden Rabia Gurses
Chief Medical Officer
—
$100.58K (4)
−$100.58K
153,054
0.0697%
$1.57M
+365.7%
Strassburger Philip C.
General Counsel
—
$89.32K (3)
−$89.32K
161,493
0.0735%
$1.65M
+3,399%
White Christopher G
Chief Business Officer
—
$78.92K (3)
−$78.92K
123,689
0.0563%
$1.27M
—
Goldstein Michael H.
President, Ophthalmology & CMO
$71.62K (2)
—
+$71.62K
313,335
0.1427%
$3.21M
+37.4%
Williams Leslie J.
Director
$19.80K (1)
—
+$19.80K
65,433
0.0298%
$670.03K
—
PEACOCK BRUCE
Director
—
— (1)
$0.00
0
0.0000%
$0.00
—
Meyers Steve Lawrence
Chief Commercial Officer
—
—
—
217,628
0.0991%
$2.23M
+42.5%
Robinson David Wayne
Global CCO
—
—
—
136,000
0.0619%
$1.39M
—
Warden Charles M
Director
—
—
—
100,464
0.0457%
$1.03M
−95.5%
Robins Jason Shand
Chief Financial Officer
—
—
—
68,097
0.0310%
$697.31K
+29.3%
Graves Adrienne L
Director
—
—
—
64,000
0.0291%
$655.36K
—
RAINES MERILEE
Director
—
—
—
60,933
0.0277%
$623.95K
—
Hong Seung Suh
Director
—
—
—
60,933
0.0277%
$623.95K
—

Individual transactions

46
Insider
Date
Role
Action
Shares
Price
Amount
Dugel Pravin
24 Aug 2026
See Remarks
Sold on a plan
21,649
$10.77
$233.16K
Heier Jeffrey S.
24 Aug 2026
Chief Scientific Officer
Sold on a plan
3,296
$10.78
$35.53K
Nayak Sanjay
24 Aug 2026
Chief Strategy Officer
Sold on a plan
1,897
$10.78
$20.45K
Kaiser Peter
24 Aug 2026
Chief Development Officer
Sold on a plan
3,035
$10.77
$32.69K
Waheed Nadia
3 Jun 2026
Chief Medical Officer
Sold on a plan
14,828
$8.27
$122.63K
Nayak Sanjay
26 May 2026
Chief Strategy Officer
Sold on a plan
1,858
$8.20
$15.24K
Heier Jeffrey S.
26 May 2026
Chief Scientific Officer
Sold on a plan
3,018
$8.20
$24.75K
Kaiser Peter
26 May 2026
Chief Development Officer
Sold on a plan
2,967
$8.20
$24.33K
Dugel Pravin
26 May 2026
See Remarks
Sold on a plan
21,156
$8.20
$173.48K
Nayak Sanjay
23 Feb 2026
Chief Strategy Officer
Sold on a plan
1,759
$8.28
$14.56K
Heier Jeffrey S.
23 Feb 2026
Chief Scientific Officer
Sold on a plan
3,057
$8.28
$25.31K
Kaiser Peter
23 Feb 2026
Chief Development Officer
Sold on a plan
2,810
$8.28
$23.27K
Dugel Pravin
23 Feb 2026
See Remarks
Sold on a plan
20,056
$8.28
$166.06K
Waheed Nadia
20 Feb 2026
Chief Medical Officer
Sold on a plan
3,510
$7.74
$27.17K
Waheed Nadia
12 Feb 2026
Chief Medical Officer
Sold on a plan
7,863
$9.04
$71.08K
Dugel Pravin
12 Feb 2026
See Remarks
Sold on a plan
124,882
$9.04
$1.13M
Nayak Sanjay
12 Feb 2026
Chief Strategy Officer
Sold on a plan
10,348
$9.04
$93.55K
Heier Jeffrey S.
24 Nov 2025
Chief Scientific Officer
Sold on a plan
3,469
$12.04
$41.77K
Kaiser Peter
24 Nov 2025
Chief Development Officer
Sold on a plan
3,007
$12.02
$36.14K
Dugel Pravin
24 Nov 2025
See Remarks
Sold on a plan
19,530
$12.04
$235.14K
Nayak Sanjay
24 Nov 2025
Chief Strategy Officer
Sold on a plan
1,878
$12.04
$22.61K
Saroj Namrata
5 Nov 2025
Chief Business Officer
Sold on a plan
25,865
$10.74
$277.79K
Anderman Todd
8 Oct 2025
Chief Legal Officer
Sold on a plan
11,132
$12.34
$137.37K
Heier Jeffrey S.
2 Oct 2025
Chief Scientific Officer
Sold on a plan
10,502
$11.04
$115.94K
Kaiser Peter
2 Oct 2025
Chief Development Officer
Sold on a plan
9,653
$11.03
$106.47K
Dugel Pravin
25 Aug 2025
See Remarks
Sold on a plan
21,494
$12.04
$258.79K
Heier Jeffrey S.
25 Aug 2025
Chief Scientific Officer
Sold on a plan
3,063
$12.04
$36.88K
Nayak Sanjay
25 Aug 2025
Chief Strategy Officer
Sold on a plan
1,885
$12.04
$22.70K
Kaiser Peter
25 Aug 2025
Chief Development Officer
Sold on a plan
3,011
$12.04
$36.25K
Waheed Nadia
2 Jun 2025
Chief Medical Officer
Sold on a plan
13,861
$8.05
$111.58K
Dugel Pravin
23 May 2025
See Remarks
Sold on a plan
21,219
$7.18
$152.35K
Heier Jeffrey S.
23 May 2025
Chief Scientific Officer
Sold on a plan
3,024
$7.18
$21.71K
Kaiser Peter
23 May 2025
Chief Development Officer
Sold on a plan
2,974
$7.17
$21.32K
Nayak Sanjay
23 May 2025
Chief Strategy Officer
Sold on a plan
1,862
$7.17
$13.35K
Nayak Sanjay
24 Feb 2025
Chief Strategy Officer
Sold on a plan
1,895
$6.84
$12.96K
Kaiser Peter
24 Feb 2025
Chief Development Officer
Sold on a plan
3,009
$6.87
$20.67K
Heier Jeffrey S.
24 Feb 2025
Chief Scientific Officer
Sold on a plan
3,061
$6.87
$21.03K
Dugel Pravin
24 Feb 2025
See Remarks
Sold on a plan
21,475
$6.87
$147.53K
Dugel Pravin
25 Nov 2024
See Remarks
Sold on a plan
20,680
$9.01
$186.33K
Nayak Sanjay
25 Nov 2024
Chief Strategy Officer
Sold on a plan
1,814
$9.00
$16.33K
Kaiser Peter
25 Nov 2024
Chief Development Officer
Sold on a plan
2,897
$9.01
$26.10K
Heier Jeffrey S.
25 Nov 2024
Chief Scientific Officer
Sold on a plan
2,948
$9.01
$26.56K
Dugel Pravin
23 Aug 2024
See Remarks
Sold on a plan
20,880
$9.02
$188.34K
Nayak Sanjay
23 Aug 2024
Chief Strategy Officer
Sold on a plan
1,832
$9.02
$16.52K
Dugel Pravin
23 May 2024
See Remarks
Sold on a plan
21,626
$5.79
$125.21K
Nayak Sanjay
23 May 2024
Chief Strategy Officer
Sold on a plan
2,274
$5.84
$13.28K
Show all 140 transactions →

What was left out

Form 4 filings counted 258
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 46
Sales straight out of an exercise 1
Sales at will 24
Transactions with no price 1
Shares from compensation/vesting 12,632,639
Sales filed before the plan box existed 6
History held since 8 Nov 2016